Basic Information
RNALocate ID: | RLID:11001339 |
RNA Symbol: | hsa-miR-30d-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-30d-5p |
RNA ID: | miRBase:MIMAT0000245 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001581 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001582 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001583 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001584 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001334 | Exosome | HCC tissues | 30542726 |
RLID:11001335 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001336 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001337 | Exosome | Renal cancer cells | 21670082 |
RLID:11001338 | Exosome | Brain tissue | 23382797 |
RLID:11001340 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001341 | Exosome | Cerebrospinal fluid | 25420022 |
RLID:11001342 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001343 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001344 | Microvesicle | Plasma | 23077538 |
RLID:11001345 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001346 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000043 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000312 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30d-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37465 |
MNDR | hsa-miR-30d-5p | Glomerulosclerosis | MNDR-E-MI-37466 |
MNDR | hsa-miR-30d-5p | Oral squamous cell carcinoma | MNDR-E-MI-37467 |
MNDR | hsa-miR-30d-5p | Large cell neuroendocrine cancer | MNDR-E-MI-37468 |
MNDR | hsa-miR-30d-5p | Medulloblastoma | MNDR-E-MI-37469 |
MNDR | hsa-miR-30d-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-37470 |
MNDR | hsa-miR-30d-5p | Lymphoma | MNDR-E-MI-37471 |
MNDR | hsa-miR-30d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37472 |
MNDR | hsa-miR-30d-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37473 |
MNDR | hsa-miR-30d-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37474 |
MNDR | hsa-miR-30d-5p | Niemann-pick disease type c | MNDR-E-MI-37475 |
MNDR | hsa-miR-30d-5p | Anaplastic thyroid carcinoma | MNDR-E-MI-37476 |
MNDR | hsa-miR-30d-5p | Dermatomyositis | MNDR-E-MI-37477 |
MNDR | hsa-miR-30d-5p | Prostate cancer | MNDR-E-MI-37478 |
MNDR | hsa-miR-30d-5p | Chronic lymphocytic leukemia | MNDR-E-MI-37479 |
MNDR | hsa-miR-30d-5p | Gastric cancer | MNDR-E-MI-37480 |
MNDR | hsa-miR-30d-5p | Gastric lymphoma | MNDR-E-MI-37481 |
MNDR | hsa-miR-30d-5p | Alzheimer disease | MNDR-E-MI-37482 |
MNDR | hsa-miR-30d-5p | Intracranial aneurysm | MNDR-E-MI-37483 |
MNDR | hsa-miR-30d-5p | Esophageal carcinoma | MNDR-E-MI-37484 |
MNDR | hsa-miR-30d-5p | Muscular dystrophy duchenne | MNDR-E-MI-37485 |
MNDR | hsa-miR-30d-5p | Head and neck cancer | MNDR-E-MI-37486 |
MNDR | hsa-miR-30d-5p | Primary biliary cirrhosis | MNDR-E-MI-37487 |
MNDR | hsa-miR-30d-5p | Leukemia | MNDR-E-MI-37488 |
MNDR | hsa-miR-30d-5p | Cardiovascular disease | MNDR-E-MI-37489 |
MNDR | hsa-miR-30d-5p | Carotid stenosis | MNDR-E-MI-37490 |
MNDR | hsa-miR-30d-5p | Lung cancer | MNDR-E-MI-37491 |
MNDR | hsa-miR-30d-5p | Down syndrome | MNDR-E-MI-37492 |
MNDR | hsa-miR-30d-5p | Parkinson disease | MNDR-E-MI-37493 |
MNDR | hsa-miR-30d-5p | Niemann-pick disease | MNDR-E-MI-37494 |
MNDR | hsa-miR-30d-5p | Basal-like breast cancer | MNDR-E-MI-37495 |
MNDR | hsa-miR-30d-5p | Thyroid cancer | MNDR-E-MI-37496 |
MNDR | hsa-miR-30d-5p | Pancreatic cancer | MNDR-E-MI-37497 |
MNDR | hsa-miR-30d-5p | Melanoma | MNDR-E-MI-37498 |
MNDR | hsa-miR-30d-5p | Rectum adenocarcinoma | MNDR-E-MI-37499 |
MNDR | hsa-miR-30d-5p | Nephroblastoma | MNDR-E-MI-37500 |
MNDR | hsa-miR-30d-5p | Colon cancer | MNDR-E-MI-37501 |
MNDR | hsa-miR-30d-5p | Ischemic attack transient | MNDR-E-MI-37502 |
MNDR | hsa-miR-30d-5p | Colon adenocarcinoma | MNDR-E-MI-37503 |
MNDR | hsa-miR-30d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37504 |
MNDR | hsa-miR-30d-5p | Familial ovarian cancer | MNDR-E-MI-37505 |
MNDR | hsa-miR-30d-5p | Prostate adenocarcinoma | MNDR-E-MI-37506 |
MNDR | hsa-miR-30d-5p | Glioblastoma | MNDR-E-MI-37507 |
MNDR | hsa-miR-30d-5p | Glioma | MNDR-E-MI-37508 |
MNDR | hsa-miR-30d-5p | Chordoma | MNDR-E-MI-37509 |
MNDR | hsa-miR-30d-5p | Temporal lobe epilepsy | MNDR-E-MI-37510 |
MNDR | hsa-miR-30d-5p | Osteosarcoma | MNDR-E-MI-37511 |
MNDR | hsa-miR-30d-5p | Inclusion body myositis | MNDR-E-MI-37512 |
MNDR | hsa-miR-30d-5p | Liver cancer | MNDR-E-MI-37513 |
MNDR | hsa-miR-30d-5p | Gastric adenocarcinoma | MNDR-E-MI-37514 |
MNDR | hsa-miR-30d-5p | Cervical squamous cell carcinoma | MNDR-E-MI-37515 |
MNDR | hsa-miR-30d-5p | Lung squamous cell carcinoma | MNDR-E-MI-37516 |
MNDR | hsa-miR-30d-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37517 |
MNDR | hsa-miR-30d-5p | Lung adenocarcinoma | MNDR-E-MI-37518 |
MNDR | hsa-miR-30d-5p | Adrenocortical cancer | MNDR-E-MI-37519 |
MNDR | hsa-miR-30d-5p | Thyroid carcinoma | MNDR-E-MI-37520 |
MNDR | hsa-miR-30d-5p | Ovarian carcinoma | MNDR-E-MI-37521 |
MNDR | hsa-miR-30d-5p | Bladder urothelial carcinoma | MNDR-E-MI-37522 |
MNDR | hsa-miR-30d-5p | Pancreatic adenocarcinoma | MNDR-E-MI-37523 |
MNDR | hsa-miR-30d-5p | Carcinoma renal cell | MNDR-E-MI-37524 |
MNDR | hsa-miR-30d-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37525 |
MNDR | hsa-miR-30d-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37526 |
MNDR | hsa-miR-30d-5p | Large cell carcinoma | MNDR-E-MI-37527 |
MNDR | hsa-miR-30d-5p | Biliary tract cancer | MNDR-E-MI-37528 |
MNDR | hsa-miR-30d-5p | Cholangiocarcinoma | MNDR-E-MI-37529 |
MNDR | hsa-miR-30d-5p | Esophageal cancer | MNDR-E-MI-37530 |
MNDR | hsa-miR-30d-5p | Lung small cell carcinoma | MNDR-E-MI-37531 |
MNDR | hsa-miR-30d-5p | Encephalopathy bovine spongiform | MNDR-E-MI-37532 |
MNDR | hsa-miR-30d-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37533 |
MNDR | hsa-miR-30d-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37534 |
MNDR | hsa-miR-30d-5p | Acute t cell leukemia | MNDR-E-MI-37535 |
MNDR | hsa-miR-30d-5p | Heart failure | MNDR-E-MI-37536 |
MNDR | hsa-miR-30d-5p | Fibromyalgia | MNDR-E-MI-37537 |
MNDR | hsa-miR-30d-5p | Encephalomyelitis | MNDR-E-MI-37538 |
MNDR | hsa-miR-30d-5p | Hepatocellular carcinoma | MNDR-E-MI-37539 |
MNDR | hsa-miR-30d-5p | Familiar ovarian carcinoma | MNDR-E-MI-37540 |
MNDR | hsa-miR-30d-5p | B-cell lymphoma | MNDR-E-MI-37541 |
MNDR | hsa-miR-30d-5p | Rheumatoid arthritis | MNDR-E-MI-37542 |
MNDR | hsa-miR-30d-5p | T-cell leukemia | MNDR-E-MI-37543 |
MNDR | hsa-miR-30d-5p | Retinoblastoma | MNDR-E-MI-37544 |
MNDR | hsa-miR-30d-5p | Burkitt lymphoma | MNDR-E-MI-37545 |
MNDR | hsa-miR-30d-5p | Crohn disease | MNDR-E-MI-37546 |
MNDR | hsa-miR-30d-5p | Tonsil cancer | MNDR-E-MI-37547 |
MNDR | hsa-miR-30d-5p | Neuromyelitis optica | MNDR-E-MI-37548 |
MNDR | hsa-miR-30d-5p | Acute myeloid leukemia | MNDR-E-MI-37549 |
MNDR | hsa-miR-30d-5p | Colorectal cancer | MNDR-E-MI-37550 |
MNDR | hsa-miR-30d-5p | Nasopharynx carcinoma | MNDR-E-MI-37551 |
MNDR | hsa-miR-30d-5p | St elevation myocardial infarction | MNDR-E-MI-37552 |
MNDR | hsa-miR-30d-5p | Cardiomegaly | MNDR-E-MI-37553 |
MNDR | hsa-miR-30d-5p | Nasopharyngeal cancer | MNDR-E-MI-37554 |
MNDR | hsa-miR-30d-5p | Sleep deprivation | MNDR-E-MI-37555 |
MNDR | hsa-miR-30d-5p | Epstein-barr virus infections | MNDR-E-MI-37556 |
MNDR | hsa-miR-30d-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37557 |
MNDR | hsa-miR-30d-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37558 |
MNDR | hsa-miR-30d-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37559 |
MNDR | hsa-miR-30d-5p | Sarcopenia | MNDR-E-MI-37560 |
MNDR | hsa-miR-30d-5p | Stroke lacunar | MNDR-E-MI-37561 |
MNDR | hsa-miR-30d-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-37562 |
MNDR | hsa-miR-30d-5p | Duke C | MNDR-E-MI-37563 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AC254633.1 | Homo sapiens | RR00032113 |
TOP